Structure Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary

Structure Therapeutics

07/08/2026 24:41

Structure Therapeutics Inc. GPCR.OQ reported a quarterly adjusted loss of 49 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.08.  The mean expectation of fourteen analysts for the quarter was for a loss of 40 cents per share. Wall Street expected results to range from -47 cents to -35 cents per share.
Reported revenue was zero​; analysts expected zero. 
Structure Therapeutics Inc.'s reported EPS for the quarter was a loss of 49 cents​.
The company reported a quarterly loss of $106.16 million.
Structure Therapeutics Inc. shares had fallen by 5.9% this quarter and lost 27.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 1.2% in the last three months.​ 
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for Structure Therapeutics Inc. is $101.00, about 47.9% above its last closing price of $52.62
This summary was machine generated from LSEG data August 6 at 11:41 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.40
-0.49
Missed
Mar. 31 2026 
-0.35
-0.35
Met
Dec. 31 2025 
-0.47
-1.22
Missed
Sep. 30 2025 
-0.35
-1.11
Missed